DNA repair gene polymorphisms and risk of pancreatic cancer

Clinical Cancer Research

Volumn 15, Issue 2, 2009, Pages 740-746

  Li, Donghui ^a,b   Suzuki, Hideo ^a   Liu, Bingrong ^a   Morris, Jeffrey ^a   Liu, Jun ^a   Okazaki, Taro ^a   Li, Yanan ^a   Chang, Ping ^a   Abbruzzese, James L ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER RISK; CIGARETTE SMOKING; CONTROLLED STUDY; DIABETES MELLITUS; DNA POLYMORPHISM; DNA REPAIR; FEMALE; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; INTERVIEW; LIG3 GENE; LIG4 GENE; MAJOR CLINICAL STUDY; MALE; OGG1 GENE; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; POLB GENE; PRIORITY JOURNAL; RAD54L GENE; RECQL GENE; TUMOR GENE;

AGED; DNA REPAIR; FEMALE; GENETIC VARIATION; GENOTYPE; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; MUTATION; PANCREATIC NEOPLASMS; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; TREATMENT OUTCOME;

EID: 59449090610     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-08-1607     Document Type: Article

References (44)

1. American Cancer Society, Cancer Figures and Facts. Atlanta (GA): American Cancer Society; 2008.
2. Bardeesy N, DePinho RA. Pancreatic cancer biology and genetics. Nat Rev Cancer 2002;2:897 -909.
3. Permuth-Wey J, Egan KM. Family history is a significant risk factor for pancreatic cancer: results from a systematic review and meta-analysis. Fam Cancer 2008. Epub ahead of print.
4. Habbe N, Langer P, Sina-Frey M, Bartsch DK. Familial pancreatic cancer syndromes. Endocrinol Metab Clin North Am 2006;35:417-30.
5. Brand RE, Lynch HT. Genotype/phenotype of familial pancreatic cancer. Endocrinol Metab Clin North Am 2006;35:405-15.
6. Anderson K, Mack TM, Silverman DT. Cancer of the pancreas. In: Schottenfeld D, Fraumeni JF, Jr., editors. Cancer Epidemiology and Prevention. 3rd ed. New York: Oxford University Press; 2006. p. 721 -62.
7. Ahlgren JD. Epidemiology and risk factors in pancreatic cancer. Semin Oncol 1996:23:241 -50.
8. WCRF (World Cancer Research Fund). Food, Nutrition, Physical Activity and Cancer: A Global Perspective. Washington (DC): World Cancer Research Fund/The American Institute for Cancer Research; 2007. p. 271 -4.
9. Suzuki H, Jiao L, Li Y, et al. Interaction of the Cytochrome P4501A2, SULT1A1 and NAT Gene Polymorphisms with Smoking and Dietary Mutagen Intake in Modification of the Risk of Pancreatic Cancer. Carcinogenesis 2008;29:1184-91.
10. Duell EJ, Holly EA, Bracci PM, Liu M, Wiencke JK, Kelsey KT. A population-based, case-control study of polymorphisms in carcinogen-metabolizing genes, smoking, and pancreatic adenocarcinoma risk. J Natl Cancer Inst 2002;94:297-306.
11. McWilliams RC, Bamlet WR, Cunningham JM, Goode EL, de Andrade M, Boardman LA,et al. Polymorphisms in DNA repair genes, smoking, and pancreatic adenocarcinoma risk. Cancer Res 2008;68:4928-35.
12. Jiao L, Bondy ML, Hassan MM, et al. Selected polymorphisms of DNA repair genes and risk of pancreatic cancer. Cancer Detect Prev 2006;30:284-91.
13. Jiao L, Hassan MM, Bondy ML, Abbruzzese JL, Evans DB, Li D. The XPD Asp312Asn and Lys751Gln polymorphisms, corresponding haplotype, and pancreatic cancer risk. Cancer Lett 2007;245:61 -8.
14. Duell EJ, Holly EA, Bracci PM, Wiencke JK, Kelsey KT. A population-based study of the Arg399Gln poly-morphism in X-ray repair cross-complementing group 1 [XRCC1] and risk of pancreatic adenocarcinoma. Cancer Res 2002;62:4630-6.
15. Jiao L, Hassan MM, Bondy ML, et al. XRCC2 and XRCC3 gene polymorphism and risk of pancreatic cancer. Am J Gastroenterol 2008;103:360-7.
16. Wilson DM III, Sofinowski TM, McNeill DR. Repair mechanisms for oxidative DNA damage. Front Biosci 2003;8:d963-81.
17. Frosina G, Fortini P, Rossi O, et al. Two pathways for base excision repair in mammalian cells. J Biol Chem 1996;271:9573-8.
18. D'Andrea AD, Grompe M. The Fanconi Anaemia/ BRCA Pathway. Nat Rev Cancer 2003;3:23-34.
19. Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer 2003;3:155-68.
20. Li D, Frazier M, Evans DB, et al. Single nucleotide polymorphisms of RecQ1, RAD54L, and ATM genes are associated with reduced survival of pancreatic cancer. J Clin Oncol 2006;24:1720-8.
21. Li D, Liu H, Jiao L, et al. Significant effect of homologous recombination DNA repair gene polymorphisms on pancreatic cancer survival. Cancer Res 2006;66:3323-30.
22. Li D, Li Y, Jiao L, et al. Effects of base excision repair gene polymorphisms on pancreatic cancer survival Int J Cancer 2007;120:1748-54.
23. Hassan MM, Wolff RA, Bondy ML, et al. Risk factors for pancreatic cancer: synergy of smoking with family history of pancreatic cancer and diabetes mellitus. Am J Gastroenterol 2007;102:2696-707.
24. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 2004;96:434-42.
25. Li D, Hassan MM. Letter of response to comments on the article entitled "Passive Smoking and Use of NoncigaretteTobacco Products and Risk for Pancreatic Cancer: Case-Control Study" published in Cancer. Cancer 2008;112:672.
26. Suga T, Ishikawa A, Kohda M, et al. Haplotype-based analysis of genes associated with risk of adverse skin reactions after radiotherapy in breast cancer patients. Int J Radiat Oncol Biol Phys 2007;69:685-93.
27. Landi S, Gemignani F, Canzian F, et al. DNA repair and cell cycle control genes and the risk of young-onset lung cancer. Cancer Res 2006;66:11062-9.
28. Hao B, Wang H, Zhou K, et al. Identification of genetic variants in base excision repair pathway and their associations with risk of esophageal squamous cell carcinoma. Cancer Res 2004;64:4378-84.
29. Zienolddiny S, Campa D, Lind H, et al. Polymor-phisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis 2006;27:560- 7.
30. Hung RJ, Brennan P, Canzian F, et al. Large-scale investigation of base excision repair genetic polymorphisms and lung cancer risk in a multicenter study. J Natl Cancer Inst 2005;97:567-76.
31. Figueroa JD, Malats N, Real FX, et al. Genetic variation in the base excision repair pathway and bladder cancer risk. Hum Genet 2007;121:233-42.
32. Moreno V, Gemignani F, Landi S, et al. Polymorphisms in genes of nucleotide and base excision repair: risk and prognosis of colorectal cancer. Clin Cancer Res 2006;12:2101 -8.
33. Zhang Y, Newcomb PA, Egan KM, et al. Genetic polymorphisms in base-excision repair pathway genes and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2006;15:353-8.
34. Liu Y, Zhou K, Zhang H, et al. Polymorphisms of LIG4 and XRCC4 involved in the NHEJ pathway interact to modify risk of glioma. Hum Mutat 2008;29:381 -9.
35. Roddam PL, Rollinson S, O'Driscoll M, Jeggo PA, Jack A, Morgan GJ. Genetic variants of NHEJ DNA li-gase IV can affect the risk of developing multiple myeloma, a tumour characterised by aberrant class switch recombination. J Med Genet 2002;39:900-5.
36. Andreae,Varon R, Sperling K, Seeger K. Polymorphisms in the DNA ligase IV gene might influence the risk of acute lymphoblastic leukemia in children. Leukemia 2007;21:2226-7.
37. Goode EL, Dunning AM, Kuschel B, et al. Effect of germ-line genetic variation on breast cancer survival in a population-based study. Cancer Res 2002;62:3052-7.
38. Mazumder B, Seshadri V, Fox PL. Translational control by the 3′-UTR: the ends specify the means. Trends Biochem Sci 2003:28:91 -8.
39. Prokopcova J, Kleibl Z, Banwell CM, Pohlreich P. The role of ATM in breast cancer development. Breast Cancer ResTreat 2007:104:121 -8.
40. Koren M, Kimmel G, Ben-Asher E, et al. ATM haplotypes and breast cancer risk in Jewish high-risk women. Br J Cancer 2006;94:1537-43.
41. Johnson N, Fletcher O, Palles C, et al. Counting potentially functional variants in BRCA1, BRCA2 and ATM predicts breast cancer susceptibility. Hum Mol Genet 2007:16:1051-7.
42. Angele S, Romestaing P, Moullan N, et al. ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity. Cancer Res 2003;63:8717-25.
43. Weiss JM, Goode EL, LadigesWC, Ulrich CM. Polymorphic variation in hOGG1 and risk of cancer: a review of the functional and epidemiologic literature. Mol Carcinog 2005;42:127-41.
44. Goode EL, Ulrich CM, Potter JD. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 2002;11:1513-30.